Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study

PURPOSE: To compare the effectiveness and safety of a drug in daily practice with the outcomes of a target non‐inferiority trial by rigorously mimickingin an observational study the trial's design features. METHODS: This cohort study was conducted using the British Clinical Practice Research Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Althunian, Turki A., de Boer, Anthonius, Groenwold, Rolf H. H., Rengerink, Katrien O., Souverein, Patrick C., Klungel, Olaf H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687233/
https://www.ncbi.nlm.nih.gov/pubmed/32537897
http://dx.doi.org/10.1002/pds.5065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687233/
https://www.ncbi.nlm.nih.gov/pubmed/32537897
http://dx.doi.org/10.1002/pds.5065

Ejemplares similares